Back to School: How biopharma can reboot drug development. Access exclusive analysis here
AMGN subsidiary Ilypsa Inc. spun out Relypsa Inc. to discover and develop non-absorbed polymeric therapeutics
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury